Your browser doesn't support javascript.
loading
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.
Scognamiglio, Giosue; De Chiara, Annarosaria; Parafioriti, Antonina; Armiraglio, Elisabetta; Fazioli, Flavio; Gallo, Michele; Aversa, Laura; Camerlingo, Rosa; Cacciatore, Francesco; Colella, Gianluca; Pili, Roberto; de Nigris, Filomena.
Afiliación
  • Scognamiglio G; Pathology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • De Chiara A; Pathology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Parafioriti A; Department of Pathology, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Del Pini - CTO, Milan, Italy.
  • Armiraglio E; Department of Pathology, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Del Pini - CTO, Milan, Italy.
  • Fazioli F; Division of Musculoskeletal Oncology Surgery, Istituto Nazionale Tumori- IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Gallo M; Division of Musculoskeletal Oncology Surgery, Istituto Nazionale Tumori- IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Aversa L; Division of Musculoskeletal Oncology Surgery, Istituto Nazionale Tumori- IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Camerlingo R; Department of Cell Biology and Biotherapy, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Cacciatore F; Department of Translational Medical Sciences, Federico II University, Naples, Italy.
  • Colella G; Department of Translational Medical Sciences, Federico II University, Naples, Italy.
  • Pili R; Department of Hematology/Oncology, Indiana University Medical School, Indianapolis, IN, USA.
  • de Nigris F; Department of Precision Medicine, University of Campania L. Vanvitelli, Naples, Italy. filomena.denigris@unicampania.it.
Br J Cancer ; 121(11): 979-982, 2019 11.
Article en En | MEDLINE | ID: mdl-31666667

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cordoma / Organoides / Descubrimiento de Drogas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Nivolumab / Inmunoterapia Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cordoma / Organoides / Descubrimiento de Drogas / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Nivolumab / Inmunoterapia Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia